Publicaciones en colaboración con investigadores/as de University of Cambridge (23)

2024

  1. Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches

    Journal of Extracellular Vesicles, Vol. 13, Núm. 2

2022

  1. Stromal oncostatin M cytokine promotes breast cancer progression by reprogramming the tumor microenvironment

    Journal of Clinical Investigation, Vol. 132, Núm. 7

2021

  1. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

2020

  1. Impact of global PTP1B deficiency on the gut barrier permeability during NASH in mice

    Molecular Metabolism, Vol. 35

  2. Modeling Parkinson’s disease neuropathology and symptoms by intranigral inoculation of preformed human α-synuclein oligomers

    International Journal of Molecular Sciences, Vol. 21, Núm. 22, pp. 1-25

2018

  1. Corrigendum to “European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS)” (Redox Biol. (2017) 13 (94–162)(S2213231717303373)(10.1016/j.redox.2017.05.007))

    Redox Biology

  2. Therapeutic relevance of the PP2A-B55 inhibitory kinase MASTL/Greatwall in breast cancer

    Cell Death and Differentiation, Vol. 25, Núm. 5, pp. 828-840

2017

  1. European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS)

    Redox Biology, Vol. 13, pp. 94-162

2016

  1. Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356

    Autophagy

  2. GM-CSF Enhances macrophage glycolytic activity in vitro and improves detection of inflammation in vivo

    Journal of Nuclear Medicine, Vol. 57, Núm. 9, pp. 1428-1435

  3. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

    Autophagy, Vol. 12, Núm. 1, pp. 1-222

  4. Overexpression of the oncostatin-M receptor in cervical squamous cell carcinoma is associated with epithelial-mesenchymal transition and poor overall survival

    British Journal of Cancer, Vol. 115, Núm. 2, pp. 212-222

2015

  1. HIF-1α and PFKFB3 mediate a tight relationship between proinflammatory activation and anerobic metabolism in atherosclerotic macrophages

    Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 35, Núm. 6, pp. 1463-1471

  2. Tailoring chitosan/collagen scaffolds for tissue engineering: Effect of composition and different crosslinking agents on scaffold properties

    Carbohydrate Polymers, Vol. 132, pp. 606-619

2013

  1. The role of GPR55 in cancer

    endoCANNABINOIDS: Actions at Non-CB1/CB2 Cannabinoid Receptors (Springer New York), pp. 115-133

2012

  1. Cannabinoids: A new hope for breast cancer therapy?

    Cancer Treatment Reviews, Vol. 38, Núm. 7, pp. 911-918

  2. Guidelines for the use and interpretation of assays for monitoring autophagy

    Autophagy, Vol. 8, Núm. 4, pp. 445-544

2011

  1. Flexible tethering of primase and DNA Pol α in the eukaryotic primosome

    Nucleic Acids Research, Vol. 39, Núm. 18, pp. 8187-8199

  2. The orphan G protein-coupled receptor GPR55 promotes cancer cell proliferation via ERK

    Oncogene, Vol. 30, Núm. 2, pp. 245-252

2010

  1. Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition

    Molecular Cancer, Vol. 9